Abstract:【Objective】 To investigate the effect of Phase Ⅰ cardiac rehabilitation on cardiac function and serum stromal interaction molecule 1 (STIM1) level in patients with ST-segment elevation myocardial infarction (STEMI) after emergency percutaneous coronary intervention (PCI). 【Methods】 A total of 100 STEMI patients who underwent emergency PCI in the Changhai Hospital and the Kongjiang Hospital from January to December 2024 were selected and randomly divided into a control group and a rehabilitation group, with 50 cases in each group. The control group received routine treatment after emergency PCI, while the rehabilitation group received Phase Ⅰ cardiac rehabilitation on the basis of routine treatment. Left ventricular ejection fraction (LVEF), N-terminal pro-brain natriuretic peptide (NT-proBNP) level, STIM1 level, physical component summary (PCS) score, mental component summary (MCS) score, peak oxygen uptake (VO2/kg), metabolic equivalent (MET), oxygen pulse (VO2/HR), ventilation-to-carbon dioxide production ratio (VE/VCO2 slope) and the occurrence of major adverse cardiovascular events (MACE) were compared between the two groups before treatment and 1 month after treatment. 【Results】 One month after treatment, the LVEF, PCS score and MCS score in the rehabilitation group were significantly higher than those in the control group (P<0.05), while the serum levels of NT-proBNP and STIM1 were significantly lower than those in the control group (P<0.05). The peak VO2/kg, MET and VO2/HR in the rehabilitation group were higher than those in the control group (P<0.05), and the VE/VCO2 slope was lower than that in the control group (P<0.05). There was no significant difference in the incidence of MACE between the two groups (P>0.05). 【Conclusion】 Phase Ⅰcardiac rehabilitation has a significant improvement effect on STEMI patients after emergency PCI. It can not only effectively improve cardiac function, reduce the risk of heart failure, but also enhance the quality of life and alleviate psychological burden of the patients. It may also promote patient recovery by reducing serum STIM1 level, which has good clinical promotion value.
钱一君, 张越月, 倪烨, 张必利, 赵娅. Ⅰ期心脏康复对STEMI患者急诊PCI术后心功能及血清STIM1水平的影响[J]. 医学临床研究, 2025, 42(12): 2046-2049.
QIAN Yijun, ZHANG Yueyue, NI Ye, et al. Effect of Phase Ⅰ Cardiac Rehabilitation on Cardiac Function and Serum STIM1 Level in STEMI Patients after Emergency PCI. JOURNAL OF CLINICAL RESEARCH, 2025, 42(12): 2046-2049.
[1] 赵翔,刘存,任明. 伴有冠状动脉完全闭塞的急性非ST段抬高型心肌梗死研究进展[J].中国心血管病研究,2023,21(4):304-308. [2] 张涛,李爱敏,张金霞,等. 急性ST段抬高型心肌梗死总缺血时间与急诊经皮冠状动脉介入治疗后1年内主要不良心血管事件发生风险的关系[J].中国循环杂志,2024,39(10):976-982. [3] 孙欣,马红彦,李静,等. 新活素联合真武汤治疗老年急性ST段抬高型心肌梗死术后心功能不全疗效观察[J].现代中西医结合杂志,2024,33(15):2141-2144. [4] 任月,田婷,韦光胜,等. Ⅰ期综合心脏康复对ST段抬高型心肌梗死急诊经皮冠状动脉介入术后患者的疗效[J].实用医学杂志,2024,40(5):682-687. [5] 刘方圆,唐楠,杨政,等. 钙传感器基质交感分子1与心血管疾病的研究进展[J].中国病理生理杂志,2019,35(2):379-384. [6] 曾鹏,秦晓玥,王义蓉,等. 钙感受器STIM1参与主动脉平滑肌细胞衰老的作用研究[J].中国病理生理杂志,2022,38(4):577-583. [7] 龚艳君,霍勇. 急性ST段抬高型心肌梗死诊断和治疗指南(2019)解读[J].中国心血管病研究,2019,17(12):1057-1061. [8] HANMER J. Predicting an SF-6D preference-based score using MCS and PCS scores from the SF-12 or SF-36 [J].Value Health,2009,12(6):958-966. [9] XU W, YANG Y M, ZHU J, et al. Predictive value of the stress hyperglycemia ratio in patients with acute ST-segment elevation myocardial infarction: insights from a multi-center observational study[J].Cardiovasc Diabetol,2022, 21(1): 48. [10] CHA J J, BAE S A, PARK D W, et al. Clinical outcomes in patients with delayed hospitalization for Non-ST-segment elevation myocardial infarction[J].J Am Coll Cardiol,2022, 79(4): 311-323. [11] VOGEL B, CLAESSEN B E, ARNOLD S V, et al. ST-segment elevation myocardial infarction[J].Nat Rev Dis Primers,2019, 5(1): 39. [12] PARK J R, AHN J H, JUNG M H, et al. Serum microRNA-185 levels and myocardial injury in patients with acute ST-segment elevation myocardial infarction[J].Int Med,2022, 61(2): 151-158. [13] 刘艳霞,史艳霞. 思维导图式多维度心脏康复护理模式在经皮冠状动脉介入治疗术后患者中的应用效果[J].医学临床研究,2025,42(8):1439-1441. [14] 王胜男,王悦,陈书慧. 八段锦联合心脏康复七步训练法干预对行心脏外科手术治疗的冠心病患者生活能力及心理状态的影响[J].医学临床研究,2024,41(3):431-433.